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ABSTRACT 
The beige mouse is an animal model for the human Chediak-Higashi syndrome, a 
disease characterized by giant lysosomes in most cell types. In mice, treatment with 
androgenic  hormones  causes  a  20-50-fold  elevation  in  at  least  one  kidney 
lysosomal  enzyme,  ~-glucuronidase.  Beige  mice  treated  with  androgen  had 
significantly  higher  kidney  ~-glucuronidase,  B-galactosidase,  and  N-acetyl-~-o- 
glucosaminidase  (hexosaminidase)  levels  than  normal  mice.  Other  androgen- 
inducible enzymes and enzyme markers for the cytosol, mitochondria, and peroxi- 
somes were not  increased in  kidney of beige mice. No significant lysosomal en- 
zyme elevation was observed in  five other organs of beige mice with  or without 
androgen treatment, nor in kidneys of beige females not treated with androgen. 
Histochemical staining for glucuronidase together with subcellular fractionation 
showed that the higher glucuronidase content of beige mouse kidney is caused by a 
striking accumulation of giant glucuronidase-containing iysosomes in tubule cells 
near  the  corticomedullary  boundary.  In  normal  mice  lysosomal  enzymes  are 
coordinately  released  into  the  lumen  of  the  kidney  tubules  and  appreciable 
amounts of lysosomal enzymes are  present  in  the urine.  Levels of urinary lyso- 
somal enzymes are much lower in beige mice than in normal mice. 
It  appears  that  lysosomes may accumulate in  beige mice because of defective 
exocytosis resulting  either from decreased intracellular motility of lysosomes or 
from  their  improper  fusion  with  the  plasma  membrane.  A  similar  defect could 
account for characteristics of the Chediak-Higashi syndrome. 
Humans with the Chediak-Higashi syndrome have 
diluted  pigmentation,  increased  susceptibility  to 
infections  and,  most  pertinent  in  regard  to  this 
study,  abnormally  large  lysosomes  in  most  cell 
types (25). The disease  is  rare, but lethal;  in the 
human population most affected individuals die by 
their  teen  years.  Lysosomes in  granulocytes  of 
affected individuals appear to be impaired in their 
ability to fuse with phagocytosed  bacteria (32, 42) 
but  the  molecular  basis  for  the  defect  remains 
unknown. 
Thus far, the disease has been described in man, 
mink, cattle, and mice (24, 25). In all species it is 
inherited as an autosomal recessive trait, and in the 
mouse its genetic locus has been precisely mapped 
on chromosome 13 (17). 
In  the  mouse  the  homologous  mutation,  first 
called slate  and then beige (28, 29), arose  sponta- 
neously  in  the  C57BL/6J  strain  (16). The beige 
mutant, C57BL/6.1 (bg/bg), probably differs from 
the  parental  C57BL/6J  (+/+)  line  only  in  the 
beige gene on chromosome 13, making the paren- 
tal  strain  an  ideal  control for experimental pur- 
poses. The phenotype of beige mice resembles that 
of Chediak-Higashi  humans including lighter coat 
color, decreased  bactericidal activity  of granulo- 
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of cells (21).  Despite the presence of morphologi- 
cally abnormal  lysosomes in Chediak-Higashi dis- 
ease,  there  are  contradictory  reports  concerning 
lysosomal  enzyme  levels.  Some  workers  have 
found  altered  lysosomal  enzyme  activity (15)  but 
these  reports  have  not  been  confirmed  by  other 
investigators (23, 41). 
A  major  increase  (20-50-fold)  occurs  in  the 
kidney level of glucuronidase  after administration 
of androgens  to  female mice (8).  The  increase  in 
enzyme  is  accompanied  by  a  considerable  hyper- 
trophy of proximal tubule cells and by an approxi- 
mately 200-fold increase in secretion of the enzyme 
into  urine  (31).  Subsequent  studies  (36)  have 
shown that induction results from an increase in de 
novo enzyme synthesis.  The rate of glucuronidase 
synthesis  after  androgenic  treatment  is  under  the 
control  of the  Gur locus,  a  cis-acting  gene in  the 
region  of  the  glucuronidase  structural  gene  on 
chromosome 5  (27,  36). 
Glucuronidase  is  an  unusual  acid  hydrolase 
enzyme  in  that  30-40%  of the  kidney  enzyme  is 
attached  to endoplasmic reticulum (26,  35).  Bind- 
ing  of  the  enzyme  to  endoplasmic  reticulum  is 
effected through  a  noncovalent  association  with a 
64,000 mol wt protein, egasyn (37). This process is 
under  the  genetic  control  of  the  Eg  locus  on 
chromosome 9 (10). 
The beige mutation  afforded the opportunity  to 
test the effect of an inherited morphological altera- 
tion  of lysosomes on lysosomal physiology in  the 
mouse  kidney.  In  proximal  tubule  cells  of  the 
mouse  kidney,  the  vacuolar  apparatus  is  actively 
involved in the processes of phagocytosis of extra- 
cellular proteins from the newly filtered urine (19, 
33,  34) and synthesis (36) and  secretion of at least 
one  lysosomal  enzyme,  /3-glucuronidase  (EC 
3.2.1.31).  An ideal genetic control is available for 
the C57BL/6J  (bg/bg)  mouse through  its normal 
C57BL/6J (+/+)  congenic counterpart,  and tech- 
niques are available for studying the synthesis and 
intracellular  processing  of glucuronidase  (35,  36, 
37). 
This  paper  presents  our  initial  observations  on 
measurements  of the effects of the beige mutation 
on  three  lysosomal  enzymes,  /~-glucuronidase,  t3- 
galactosidase (EC  3.2.1.23),  and  N-acetylglucosa- 
minidase (hexosaminidase) (EC 3.2.1.30).  We have 
found that  in normal mice a  major fraction of the 
kidney content of each of these lysosomal enzymes 
is secreted daily from kidney proximal tubule cells 
after  female  mice  are  treated  with  androgen. 
Under  the  same  conditions  there  is  a  markedly 
lowered secretion of all three lysosomal enzymes in 
the  beige  mouse,  resulting  in  two-  to  fourfold 
higher  kidney  enzyme  levels.  The  beige  effect 
appears  to  be  lysosome  specific  in  that  other 
androgen-inducible,  but  nonlysosomal,  enzymes 
are not affected. Similarly unaffected are enzymes 
of three other subcellular compartments. 
MATERIALS  AND METHODS 
A nimals 
Female inbred  C57BL/6J (+/+), C57BL/6J (+/bg), 
and  C57BL/6J  (bg/bg) mice  were  obtained  from  the 
Jackson Laboratory, Bar Harbor, Me. and were utilized 
at  8-16 wk  of age.  The animals were  maintained  on a 
12-h light,  12-h dark  schedule,  and  fed  ad  libitum  on 
Rockland  Mouse  Breeder  Diet  (Teklab,  Inc.,  Mon- 
mouth,  III.)  containing  17%  minimum  crude  protein, 
10%  minimum  crude  fat,  and  2.5%  maximum  crude 
fiber. 
Induction and Preparation  of Tissues 
Dihydrotestosterone suspended  at 50 mg/ml in olive 
oil was administered by subcutaneous injection (36). Al- 
ternatively,  75-rag  testosterone  pellets  were  implanted 
subcutaneously  and  remained throughout  the induction 
period.  Mice were killed  by exposure to carbon dioxide 
gas  or  by  cervical  dislocation.  Excised  tissues  were 
weighed and homogenized for 1 min in approximately 10 
vol (wt/vol) of ice-cold 0.25 M sucrose containing 0.02 M 
imidazole-HCI, pH 7.4, with a 13-mm Polytron homoge- 
nizer  (Kinematica  GMBH,  Lucerne)  at  setting  4.8. 
Homogenates were stored at -20~  except where other- 
wise specified. 
Assays 
A fluorimetric assay  with 0.4 mM 4-methylumbellife- 
ryI-B-D glucuronide (final assay  concentration)  as sub- 
strate was used  for glucuronidase assays.  Substrate was 
added  at 0~  to homogenate or urine diluted in 0.1  M 
sodium  acetate  buffer,  pH  4.6,  containing 0.2%  Triton 
X-100 to give a final volume of 0.1 ml. The mixture was 
incubated at 37~  for 10-30 min after which the reaction 
was terminated by immersion in an ice bath followed by 
adding  I  ml  0.1  M  sodium  carbonate.  Fluorescence, 
corrected for substrate blank, was determined relative to 
a  standard  4-methylumbelliferone  solution,  using  an 
Aminco Fluoro-Colorimeter (American Instrument Co., 
Silver Spring, Md.) equipped with an excitation interfer- 
ence filter of peak wavelength 360 nm and an emission 
filter passing  wavelengths  above 415 nm. 
fl-Galactosidase  was  assayed  with  0.22  mM  4- 
methylumbelliferyl-~-D  galactoside as the substrate.  Sub- 
strate was  added  at 0~  to tissue  homogenate or urine 
diluted in 0.1 M sodium citrate buffer, pH 3.5, containing 
0.05% Triton X-100 to give a final volume of 0.9 ml. The 
mixture was incubated  at 37~  for 10-30 min after which 
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sodium carbonate. Fluorescence was determined against 
a  substrate  blank  and  standard  as  described  for  the 
glucuronidase assay. 
A  spectrophotometric assay  with  4.0  mM  parani- 
trophenyl-2-acetamido-2-deoxy-/$-o-glucopyranoside as 
the substrate was used  to  assay hexosaminidase. Sub- 
strate was added at 0~  to homogenate or urine diluted 
in 0.1 M sodium citrate buffer, pH 4.5, containing 0.1 M 
NaCI to give a  final  volume  of I ml. The mixture was 
incubated at  37~  for 30  min  after which  the reaction 
was terminated by immersion in an ice bath followed by 
adding 0.2 ml 30% trichloroacetic acid. After mixing, the 
tubes were centrifuged at 1,000g for 10 min. Supernatant 
solutions were transferred to tubes containing 0.2 ml of 
5.0  M  2-amino-2-methyl-l:3 propanediol. The  absorb- 
ance of released p-nitrophenol was measured at 415 nm 
(Ecru  =  14,000). 
Succinate dehydrogenasc (EC  1.3.99.1) was  assayed 
by the spectrophotometric assay described by Veeger et 
al. (38). Freshly prepared tissue homogenates were used. 
The reaction was proportional to both time and homoge- 
nate concentration. 
A spectrophotometric assay for o-amino acid oxidase 
(EC  1.4.3.3) with  o-phenylalanine  as  substrate  was 
utilized according to the method of Wellner and Lichten- 
berg (40).  Freshly prepared  kidney  homogenates were 
used.  o-Amino  acid  oxidase  activity  was  determined 
from  its  absorbancy at  300  nm  (E,=  =  9,360  for the 
product phenylpyruvate) in I M borate-arsenate solution. 
For alcohol dehydrogenase (EC  1.1.1.2) assays, fresh 
kidney extracts were centrifuged at  1130,000 g for 1 h to 
remove mitochondrial NADH  oxidase activity.  To  re- 
move  endogenous  substrates,  aliquots  (0.4  ml)  were 
rapidly chromatographed at room temperature on Seph- 
adex  G-25  columns of 6  ml  bed  vol  which  had  been 
equilibrated with 0.033 M pyrophosphate buffer, pH 8.8. 
The  void  volume  was  used  for  assay.  The  reaction 
mixture contained 30 mM sodium pyrophosphate buffer, 
pH  8.8,  20  mM  ethanol, and  8 mM  NAD  §  Solutions 
were first incubated for 10 rain at 25~  minus ethanol to 
remove  residual  traces  of endogenous substrates. The 
reaction, in  a  constant-temperature cell  housing main- 
tained at 25~  was started by adding ethanol and was 
followed by measuring the fluorescence of NADH in an 
Aminco Fluoro-Colorimeter attached to a  recorder and 
containing  filters  identical  to  those  described  for  the 
glucuronidase assay.  The  amount  of NADH  produced 
was calculated using a standard NADH solution. 
For all enzyme assays, one unit of activity is defined as 
the  amount  of  enzyme  required  to  form  1 vmol  of 
product per hour. 
Analytical Methods 
Protein  concentrations  were  determined  using  the 
microbiuret procedure of Goa (11). The phenol-sulfuric 
acid colorimetric method described by DuBois et al. (2) 
was  used  for  analyzing  carbohydrates  and  reducing 
sugars.  Total lipid content was determined according to 
the procedure of Bligh and Dyer (1). 
Electrophoresis 
Polyacrylamide gel electrophoresis of tissue homoge- 
hates and subeellular fractions was done by the method 
described by Swank and Paigen (35) and the gels were 
stained specifically for glucuronidase (13). U rine samples 
were dialyzed at 4~  overnight against 0.25  M sucrose 
containing 0.02  M  imidazole-HCl, pH 7.4,  before elec- 
trophoresis. 
Subcellular Fractionation 
The  procedure  was  a  modification of that  used  by 
Ganschow and Paigen (10). Kidneys were added to 10 vol 
of chilled 0.25  M  sucrose containing 0.02 M imidazole- 
HCI buffer, pH 7.4, and homogenized at 0~  using eight 
full  strokes with  a  Potter-Elvehjem homogenizer. The 
homogenate was  filtered through four layers of gauze. 
An  aliquot  of  the  filtrates  (whole  homogenate)  was 
centrifuged at  100,000 g for 30 min. The cytosol-soluble 
fraction was saved and the pellet was resuspended in 0.02 
M  imidazole-HCl buffer,  pH  7.4.  The suspension was 
incubated at 4~  for 30 min to rupture the osmotically 
sensitive lysosomes. After centrifugation at 100,000 g for 
30 min, the supernate (lysosomal extract) was removed 
and 0.1  vol of 2.5 M sucrose was added to the lysosomal 
extract to prevent clumping after freezing  and thawing. 
The pellet (microsomes) was washed by resuspending in 
0.02  M  imidazole-HCl,  pH  7.4,  and  centrifuging  at 
100,000 g for 30 rain. The supernate (microsomal wash) 
was  saved  and  the  pellet  containing  the  microsome 
fraction  was  resuspended  to  the  whole  homogenate 
volume  with 0.25  M  sucrose containing 0.02  M  imid- 
azole-HCl buffer,  pH  7.4. 
Urine Collection 
Mouse  metabolism  cages  equipped  with  food  and 
water dispensers and containing six mice each were used. 
Urine was collected over several consecutive 24-h periods 
into  50-ml  flasks  containing  5  ml  mineral  oil  but  no 
preservative.  Samples were  clarified  by  centrifuging at 
1,000 g for l0 rain and stored at  -20~ 
Histology 
Kidneys were  fixed  in  10%  buffered  Formalin  and 
embedded in paraffin for sectioning and routine hema- 
toxylin  and eosin staining. 
The histochemical staining of glucuronidase in frozen 
sections  of  kidney  was  demonstrated  by  the  napthol 
AS-Bi  glucuronide:  and  hexazonium-pararosanilin 
method described by Hayashi (13). 
Immunochemical Quantitation 
of Glucuronidase 
Single radial immunodiffusion was utilized to quanti- 
rate  the  enzyme  in  kidney  homogenates  and  urine 
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(18).  A  monospecific  goat  antibody  prepared  against 
purified  mouse glucuronidase was the gift of Dr.  Shiro 
Tomino. 
Chemicals 
B-Nitrophenyl-2-acetamido-2-deoxy  ~-o-glycopyran- 
oside,  and  4-methylumbelliferyl  galactoside  were  ob- 
tained from  Koch-Light Laboratories,  Ltd,  Colnbrook, 
England.  Napthol  AS-BI  B-D-glucuronide,  5  a-andro- 
stan-17B-OL-3-one  (dihydrotestosterone) and  4-methyl- 
umbelliferyI-B-o-glucuronide,  NAD +,  FAD,  and  2,6- 
dichlorophenol-indophenol were  from  Sigma Chemical 
Co., St. Louis, Mo. Testosterone (75 mg Oreton pellets) 
was generously provided by the Schering Corp.,  Kenil- 
worth, N.J.  The 2-amino-2-methyl 1:3 propanediol was 
obtained from Commercial Solvents Corp. All chemicals 
utilized were reagent grade. 
RESULTS 
Lysosomal  Enzyme  Levels in Beige and 
Normal  Mice 
To determine whether any change in  lysosomal 
enzyme activity accompanies the presence of mor- 
phologically  altered  lysosomes  in  beige  mice,  the 
activities of glucuronidase, galactosidase, and hex- 
osaminidase  were  measured  in  organs  of control 
females  and  females  treated  for  23  days  with 
androgen. 
Table  i  shows  that  there  are  no  significant 
differences between control beige and normal mice 
for  the  three  acid  hydrolases  in  all  the  organs 
tested  with  the  single  exception  of kidney  hexos- 
aminidase.  This similarity is somewhat  surprising 
in view of the fact that enlarged granules have been 
reported  in all of these organs of beige mice but is 
consistent  with  the  reports  of other  workers  (23, 
41). 
Enzyme levels were also determined in organs of 
mice  treated  with  testosterone  for  23  days.  This 
treatment is known to increase maximally the rate 
of  synthesis  of  glucuronidase  in  mouse  kidney 
proximal tubules (36).  Table I shows that in liver, 
spleen,  lung,  heart,  and  brain  the  treated  mutant 
and  normal  mice  do  not  differ  from  each  other. 
Comparison  of  the  data  in  Table  I  shows  that 
testosterone  treatment  caused  no  significant  in- 
creases in these organ enzyme levels. However,  in 
kidney  the  activity  of  glucuronidase  is  greatly 
increased  in  both  normal  and  beige  mice  after 
treatment  with  androgen,  and  the  small  increase 
seen in hexosaminidase is statistically significant. 
TABLE  I 
Activities of  L  ysosomal Enzymes in Organs of Untreated and Androgen- Treated C57BL/6J Normal (+ / + ) and 
Beige (bg/bg) Mice 
Enzyme activity (U/g) 
Organ  Glucuronidase  Galactosidase  Hexosaminidase 
(+/+)  (bg/bg)  (+/+)  (bg/bg)  (+/+)  (bg/bg) 
Untreated 
Kidney  7.38  •  0.65  10.4 4-  1.3  26.7  •  3.4  33.4 4. 4.9  282  4. 13  365  4. 26 
Liver  22.9 +  1.2  25.0 4- 2.2  14.3 +  2.0  9.1  4. 2.0  294 4.  13  364  •  48 
Spleen  27.3  4. 1.7  30.6 4- 2.4  30.5  •  3.7  23.9 •  2.4  917 •  71  934 •  57 
Lung  10.2 •  0.3  10.8 4. 0.65  3.3  •  0.1  3.6  4. 0.5  214  •  22  286 •  35 
Heart  0.75  •  0.96 •  1.6 •  1.5 •  38.4  4-0.8  49.8 4-6.1 
Brain  1.2 •  0.07  1.3 a: 0.06  2.7 •  0.1  2.4 •  0.2  206 4- 12  232 4- 6.4 
Androgen-treated 
Kidney  121  •  353  4- 14  26.4 •  40.8  •  1.1  345  4- 16  492 • 
Liver  34.0 4- 1.4  30.4 4- 1.1  13.7 •  1.7  9.3  •  0.02  272  •  20  208 4- 6.2 
Spleen  32.3 •  4.5  34.3  -4- 3.5  30.9  4. 1.8  19.8 4. 1.3  874 •  105  820 •  85 
Lung  8.45  •  0.36  9.18  4. 0.9  4.6 •  0.4  2.9 4- 0.05  213 4- 8  239 •  23 
Heart  1.13 4- 0.04  1.28 •  0.04  2.1  •  0.3  1.5 4- 0.1  53.0 4- 1.6  50.0 4- 2.3 
Brain  1.40 •  0.05  1.38 4- 0.08  3.0 4- 0.3  2.0 •  0.05  217 •  6.2  221  4- 19 
Values  are  mean  4-  SEM  for three or more animals.  Treated  mice were  induced for 23 days with testosterone. 
Untreated  normal and  beige  mice have significantly different (P  <  0.05) kidney hexosaminidase levels. Kidney 
activities are significantly higher in treated beige mice for glucuronidase (P <  0.001),  galactosidase (P <  0.001) and 
hexosaminidase (P <  0.01). 
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FIGURE [  Time course  of glucuronidase  induction by 
dihydrotestosterone  in  kidney  of  normal  (+/+)  and 
beige (bg/bg) mice and their F~ (bg/+) progeny. Four 
mice were analyzed at each time point. The vertical bars 
represent standard deviations. 
Comparison of the values for induced beige and 
induced  normal mouse kidney shows that  for all 
three  enzymes,  levels  in  the  beige  mutant  are 
significantly  elevated  over  those  found  in  the 
normal mouse. 
The  major difference that  we have detected in 
lysosomal activity between normal and beige mice 
is  the  markedly  higher  enzyme  content  after 
induction  in  the  kidneys  of beige  mice.  Because 
this  increase  is  most  pronounced  for  glucuroni- 
dase, and because the mechanism of induction for 
this  enzyme  in  mouse  kidney  is  by far  the  best 
understood among the lysosomal enzymes (27), we 
chose  to  further  characterize this enzyme  in  the 
kidneys of beige and normal mice. 
There was little difference in the time course of 
glucuronidase induction in beige and normal mice 
before d~.y 7 (Fig. 1). However, after this time the 
rate  of  increase  of gtucuronidase  in  beige  mice 
accelerates, until by day 23 the kidney glucuroni- 
dase activity in these animals is three times that of 
their  normal  counterparts.  The  induction  of the 
enzyme  in  kidneys  of  the  F1  heterozygote  is 
indistinguishable from that of normal mice. Thus, 
the  higher  glucuronidase  activity  in  kidney  of 
androgen-stimulated beige mice is recessive as are 
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FIGURE 2  Quantitation of glucuronidase  molecules in 
kidney  of  normal  and  beige  mice  by  single  radial 
immunodiffusion. Three dilutions of glucuronidase activ- 
ity from kidney of beige and normal mice treated for 23 
days with testosterone  were added to wells of a  plate 
containing  antimouse  glucuronidase  globulin  in  agar. 
After 48 h of incubation at room temperature in a moist 
chamber,  plates were specifically stained for glucuroni- 
dase activity with napthol  AS-BI glucuronide, and ring 
diameters were measured. Each point is the average of at 
least nine measurements. 
all other known  phenotypic characteristics of the 
beige mutation. 
The  higher  glucuronidase-specific  activity  in 
beige kidney results from an accumulation of three 
times  the  number  of enzyme  molecules and  not 
from  activation  of  pre-existing  molecules.  The 
amount  of  enzyme  antigen  relative  to  enzyme 
activity was tested using single radial immunodif- 
fusion  analysis with  a  monospecific antibody to 
mouse glucuronidase (Fig. 2). Identical ring diam- 
eters  were  obtained  at  three  different  levels  of 
applied  enzyme  activity,  proving  that  the  same 
number of enzyme units react per unit of antibody 
in  beige  and  normal  mice,  Thus,  the  elevated 
glucuronidase level in  the tubule cells of induced 
beige mice must be due to excess accumulation of 
glucuronidase molecules, not to activation of pre- 
existing enzyme moieties or synthesis of different 
species of enzyme with glucuronidase activity. 
Specificity of Beige  Gene Action on 
Cellular  Organelles 
and Molecular Components 
To  test whether the  beige alteration is specific 
for lysosomal enzymes of kidney, we quantitated 
o-amino  acid  oxidase,  succinate  dehydrogenase, 
and  alcohol dehydrogenase,  markers  for  peroxi- 
somes, mitochondria, and cell sap, respectively. In 
addition,  we  tested  for  accumulation  of  total 
778  THE JOURNAL OF CELL  BIOLOGY  ￿9  VOLUME 67,  1975 TABLE 11 
Activities of Nonlysosomal Enzymes in Kidneys of Normal and Beige Mice 
Androgen  D-Amino  acid  Succinate  Alcohol 
Genotype  treatment  oxidasr  dehydrogenasr  dehydrogenasr 
U/g kidney  U/g kidney  U/g protein 
C57BL/6J (+/+)  -  187 :~ 9  52.8 •  4.8  14,9•  1.7 
C57BL/6J (bg/bg)  -  166 •  7  62.4 •  3.3  20.2•  4.2 
C57BL/6J (+/+)  +  351 •  11  46.5 •  3.4  137•  I1 
C57BL/6J (bg/bg)  +  389 •  20  52.8 •  3.4  102•  8 
Values  are mean +  SEM for four oi" more animals. Activities of the three enzymes are not significantly  different in 
normal and beige mice whether untreated or treated with androgen. 
TABLE 11I 
Carbohydrate, Lipid, and Protein in Kidneys of Normal and Beige Mice 
Androgen 
Genotype  treatment  Carbohydrate  Lipid  Protein 
mg/g kidney  mg/g kidney  mg/g kidney 
C57BL/6J (+/+)  -  -  -  202 -4- 4.0 
C57BL/6J (bg/bg)  -  -  -  198 •  1.7 
C57BL/6J (+/+)  +  7.71 •  0.27  16.7 •  0.25  206 •  2.9 
C57BL/6J (bg/bg)  +  8.58 •  0.15  19.7 •  2.0  216 •  I I.0 
Androgen treatment was for 23 days. Values are mean -4- SEM for four animals. 
carbohydrate, lipid, and protein in kidneys of beige 
mice. 
The  data  show  that  there  is  no  significant 
difference  between  beige  and  normal  mice in  the 
kidney  levels  of  any  of  the  three  nonlysosomal 
enzymes (Table  IlL  Like glucuronidase,  D-amino 
acid oxidase and alcohol dehydrogenase are induc- 
ible  by  androgens,  2-  and  10-fold,  respectively. 
However,  unlike  glucuronidase,  the  hormone- 
elevated  levels are  identical  in  beige  and  normal 
mice. Also, unlike the lysosomal enzymes, none of 
these enzymes could be detected in urine of control 
or treated  mice. 
The  beige  mutation  has  no effect on  carbohy* 
drate,  lipid, or protein concentrations in kidney of 
androgen-treated  mice (Table  IIl).  While  kidney 
protein  concentration  does  not  differ  in  control 
and  androgen-treated  beige and  normal  mice, the 
total  weight  of  kidney  is  significantly  higher  in 
beige  mice  than  in  normal  mice  after  androgen 
treatment.  Fig.  3  shows  that  normal  kidneys 
hypertrophy  from  0.2  g  to  0.35  g  during  the  23 
days  of  hormone  treatment,  while  beige  mouse 
kidneys  hypertrophy  to  0.45  g.  In  contrast,  liver 
weights of normal and mutant mice (Fig. 3) change 
in  parallel  throughout  the  hormonal  treatment. 
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FIGURE  3  Time  course  of  wet  weight  change  as  a 
function of induction time for kidney and liver of normal 
(--O--) and beige (---O--) mice. Each point represents 
the mean •  standard deviation for four or more animals. 
Because  of  the  larger  kidney  size  of  androgen- 
treated  beige  mice,  the  increase  in  total  kidney 
content of each lysosomal enzyme in beige mice is 
actually 20-30% greater than indicated by the data 
of Table  [. 
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FIGURE  4  Subcellular  localization  of  glucuronidase 
electrophoretic  components.  Homogenates were pre- 
pared from kidneys of 23-day induced normal C57BL/6J 
(+/+) (  ) and beige C57BL/6J  (bg/bg) (  ....  ) 
mice. Urine  was  from 27-day induced mice. Osmotic 
shock  fractions  and  urine,  prepared as  described in 
Materials and Methods, were subjected to polyacrylam- 
ide gel electrophoresis and then scanned at 550 nm after 
staining for glucuronidase activity with napthol AS-BI 
#-o-glucuronide. Units of glucuronidase electrophoresed 
for normal and beige mice, respectively,  for each fraction 
were whole homogenate: 0.037 and  0.030, lysosomal: 
0.023 and 0.024, microsomal: 0.014 and 0.014, and urine: 
0.007 and 0.007. 
Glucuronidase in Induced Beige 
Mouse Kidney is Lysosomal 
Glucuronidase has been reported to be present in 
both  lysosomes  and  endoplasmic  reticulum  in 
mouse  kidney  (35).  In  order  to  determine  the 
subcellular location of the increased glucuronidase 
in  kidneys of  androgen-treated beige  mice, both 
fractionation and histochemical studies were  un- 
dertaken. 
Mouse kidney glucuronidase includes at least six 
electrophoretically separable forms of the enzyme 
(Fig.  4)  which  are  specifically  associated  with 
different subcellular fractions (35). In normal mice 
electrophoretic  component  L  is  concentrated  in 
lysosomes and soluble fraction (not shown), while 
bands X and M~, M2, Ms, and M, are found only 
in  the  microsomal fraction.  Consistent with  the 
TABLE  IV 
Distribution of Glucuronidase Etectrophoretic 
Components In A ndrogen-Treated Normal and 
Beige Mice 
Glucuronidase  activity  (Units/g  Kidney) 
Electrophoretic 
component  C57BL/6J  (+/+)  C57BL/6J  (bg/bg) 
U  /g kidney  U  /g kidney 
L  80.0 •  1.5  280 •  7.1 
X  6.0 •  1.2  6.3 •  1.1 
M1  20.0 •  2.2  23.7 •  0.21 
M2  6.7 •  0.59  10.0 a: 0.19 
Ms  2.7 •  0.21  3.0 :~ 0.59 
M,  2.7 •  0.12  * 
Total  118 •  2.3  323 •  6.4 
Whole kidney homogenates prepared from 21-, 22-, and 
23-day dihydrotestosterone-treated  normal  and  beige 
mice were electrophoresed. The gels were scanned at 550 
nm after staining for glucuronidasr activity with napthol 
AS-B!  glucuronide.  Units  of  glucuronidase  electro- 
phoresed were 0.025 and 0.024 for normal and  beige 
mice, respectively. Values are mean +  SEM for three 
experiments. 
* Detectable but too low to quantitate. 
capacity of kidney to extrude lysosomal enzymes, 
band  L  is  the  only  electrophoretic  component 
found  in urine.  Electrophoretic  analysis of urine 
and of subcellular fractions of kidney prepared by 
osmotic shock  proved  that  this distribution like- 
wise  holds  for  beige  mice.  Furthermore,  as  evi- 
denced by the tracings of Fig. 4, no new molecular 
forms  of  glucuronidase  occur  in  beige  mouse 
kidney  despite  a  threefold  elevation  in  enzyme 
level. 
Quantitative densitometry of these electropho- 
retic bands in extracts of induced kidney of beige 
and  normal  mice  (Table  IV)  showed  that  beige 
mice contain 280 U/g kidney in band L as opposed 
to only 80 U/g kidney in band L of normal mice, a 
highly significant difference. However, differences 
between  the  two  types  of  mice  in  the  specific 
activity of the various microsomal forms X,  Mr, 
M2, Ms, and M, were  not significant. 
Figs. 5-7 illustrate some morphological charac- 
teristics  of normal and  beige  mouse  kidney and 
document that, after androgen treatment, most of 
the cellular glucuronidase activity in the beige mice 
is located within the giant granules. 
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mice is readily demonstrated by hematoxylin and 
eosin  staining.  While few enlarged clear granules 
are  visible  in  sections  of kidney  from  untreated 
beige  mice  (Fig.  5  a),  after  androgen  treatment 
large  numbers  of giant  granules  (up  to  11  #m 
diameter) are visible  in the tubule cells, especially 
in  the corticomedullary  region  (Fig.  5  b).  Many 
cells  in this region, in fact, appear to be engorged 
with  these  granules,  with  some  single  granules 
apparently occupying most of the cellular volume. 
In  contrast,  we  have  not detected  such  enlarged 
granules in kidney of normal mice before (Fig. 5 c) 
or after (Fig. 5 d) androgen treatment. The tubule 
cells  of hormone-treated  normal  and  beige  mice 
are noticeably enlarged when compared with con- 
trol mice. The increased cellular size  is especially 
apparent in treated beige mice whose tubules have 
very little visible lumen. This swelling is apparently 
due to the presence of the huge granules and may 
explain  the  measurably  larger  increase  in  kidney 
weight  of beige  mice  found  after  treatment  with 
androgens (Fig. 3). 
In tubule cells of androgen-treated normal mice 
specifically stained for glucuronidase activity (Fig. 
6 a, b),  granules,  presumably lysosomes, are con- 
centrated at the apical portion of the cell near the 
tubule lumen and all lysosomes are approximately 
the same size (about  1.8 #m maximum diameter). 
No  enzyme activity  was  detected  in  cells  of the 
medulla. Lysosomes in cells of the outer cortex are 
small,  being  equal  in  size  to  the  lysosomes  of 
normal  mouse  kidney  cortex.  Cells  in  the  cor- 
ticomedullary  region,  however,  contain  much 
larger lysosomes (up to 11 ~m) which showed very 
intense  glucuronidase  staining.  In  general,  the 
lysosomes  in  tubules  of beige  mice  are  concen- 
trated  at  the  apical  side  of the  cell,  although  in 
many  instances  the  enlarged  lysosomes  occupy 
most of the cellular volume. Comparison of Figs. 
6 a  and  7 a  likewise  shows  that  the  tubules  of 
androgen-treated beige mice have a less conspicu- 
ous lumen than comparable cells  of normal mice, 
in  confirmation  of  the  hematoxylin  and  eosin 
results. 
Table V lists confirmatory data on the subcellu- 
lar  localization  of glucuronidase in  induced beige 
kidney from experiments in which fractionation is 
accomplished by the osmotic shock technique.  In 
normal mouse kidney, about 30% of the enzyme is 
present  in  a  soluble  (cytosol)  fraction.  Approxi- 
mately the same percent  is found in  the osmotic- 
ally  sensitive  particle  fraction  (lysosomes),  and 
about  20%  cannot  be  washed  off the  remaining 
particles  (microsomes)  by  hypotonic  buffer.  In 
beige mice almost all  of the increased  activity of 
whole  homogenate  can  be  accounted  for  by  in- 
creased  activity  in  the  soluble  and  lysosomal 
fractions  which  comprise  60%  and  20%,  respec- 
tively, of the recovered homogenate activity. There 
is, likewise,  a doubling of units of glucuronidase in 
the  microsomal  fraction  in  beige  mice,  but  the 
percent microsomal enzyme in beige is less than in 
normal  mice.  Also,  densitometry  (not  shown) of 
the isolated microsomal fraction revealed that 90% 
of the increase  in  microsomal fraction activity in 
kidney  of  beige  mice  is  accounted  for  by  the 
increase  in  component  L.  The  increased  level  of 
soluble  enzyme  probably  is  a  reflection  of  the 
5-10-fold increased size of beige lysosomes which 
may render them more labile during homogeniza- 
tion. Neither very gentle homogenization nor prior 
in  vivo  administration  of  lysosomal  stabilizing 
agents  such  as  cortisol  has  reduced  the  percent 
enzyme released into the soluble fraction of kidney 
extracts of cells of beige mice (Swank, unpublished 
observations). 
Taken  together,  the evidence  from electropho- 
retic analyses, histochemical staining, and subcel- 
lular fractionation suggest that most, if not all, the 
greater  induction  of glucuronidase  in  kidney  of 
beige mice can be accounted for by accumulation 
of enzyme  in  the  giant  lysosomes  of the  tubule 
cells. 
Abnormal Secretion of L ysosomai 
Enzymes by Beige Mice 
A  possible  basis  for the  higher  lysosomal  en- 
zyme content in kidney tubule cells of beige mice is 
that  these  cells  are  defective  in  extrusion  of 
lysosomal contents  into the tubule  lumen.  Secre- 
tion is a major mechanism of removal of lysosomal 
enzymes from  mouse kidney, especially after ad- 
ministration of androgen (Table VI). In androgen- 
treated  normal mice, for example, 41%, 97%, and 
12% of the total kidney content of glucuronidase, 
galactosidase,  and  hexosaminidase,  respectively, 
are secreted daily. The relatively small percentage 
of kidney hexosaminidase secreted may reflect the 
fact that a  large fraction of the kidney content of 
this enzyme is known to be in the medulla  rather 
than  in  actively  secreting  proximal  tubule  cells 
(12). 
BRANDT, ELLIOTT,  AND SWANK  Defective  Lysosomal Enzyme Secretion in Beige Mice  781 FIGURE 5  Hematoxylin- and eosin-stained sections of the kidney  corticomeduUary region  of beige and 
normal mice (￿  400). (a) Untreated beige mouse kidney. There are very few large clear granules (arrow) in 
tubule cells.  The tubules are  not swollen  and have  readily  visible  lumens.  (b)  Kidney of a  beige mouse 
treated 14 days with testosterone. All tubule cells arc r  with large clear granules (arrow) which often 
are much larger than the darkly staining nuclei.  The cells  show extensive  hypertrophy and lumens are 
obscured. (c)  Untreated normal mouse kidney,  Darkly  staining granules are  nuclei.  Note that tubules 
(arrow) contain no clear granules, are not hypertrophied, and lumens are readily  visible. (d) Kidney of a 
normal mouse treated for 14 days with androgen. Tubule cells (arrow) contain no visible granules, hut are 
very much hypertrophied when compared to tubules from untreated mice. 
782  THE JOURNAL OF CELL BIOLOGY ￿9 VOLUME 67,  1975 FIGURE 6  Localization by histochcmical staining with napthol AS-BI B-D-glucuronide ofglucuronidase in 
kidney of normal mice treated for 23 days with testosterone. (a) Medulla with no glucuronidasr activity is to 
the left (x  400).  The small granules (filled arrow) are clustered in the apical region of the tubule cells, 
surrounding the lumen. Open arrow shows a nucleus. (b) Localization of glucuronidasr in kidney of normal 
mice treated  for  23  days  with testosterone (x  200).  Glucuronidasr  activity is found  in  small discrete 
granules in proximal tubules (arrow) throughout the cortex. 
783 FIGURE 7  Localization of glucuronidase in corticomedullary region of beige mice treated for 23 days with 
testosterone. (a) Kidney sections were specifically stained for glucuronidase activity using napthol AS-BI 
//-o-glucuronide (￿  400).  Medulla with no glucuronidase activity is to the left. Most tubules contain giant 
lysosomes (filled arrows), larger in size than nuclei (open arrow). (b) Glucuronidase activity is throughout 
the  cortex  in  discrete  granules  (x  200).  However,  the  granules  are  much  larger  in  tubules  of  the 
corticomedullary region (filled arrows) than in tubules of outer cortex (open arrow). 
784  THE JOURNAL OF CELL BIOLOGY '  VOLUME 67,  1975 Beige  mice  secrete  significantly  fewer  units  of 
the  three  lysosomal  enzymes  than  their  normal 
counterparts with the sole exception ofhexosamin- 
idase of untreated animals.  Most noteworthy is the 
finding that in androgen-treated mice, where secre- 
tion  is  a  major  mechanism  of  removal  of these 
enzymes,  beige  mice  secrete  only  one-third  to 
one-fourth as much of all three lysosomal enzymes 
as normal  mice. 
Enzyme assays on various dilutions of beige and 
TABLE V 
Glucuronidase Activity D~tribution Among 
SubceHular Fractions Prepared by Osmotic Shock 
Treatment 
Glucuronidase activity 
Subcellular  C57BL/6J  C57BL/6J 
fraction  (+/+)  (bg/bg) 
U/g kidney  U/g kidney 
Whole homogenate  118 •  2.3  322 •  6.4 
Soluble  32.7 + 0.9  172 •  8.7 
Lysosome  42.1 +  1.2  59.9 •  1.2 
Microsome wash  2.79 4- 0. I  5.68 •  0.4 
Microsome  20.4 •  0.8  43.6 •  1.8 
Recovery (%)  83.2 4- 0.8  87.2 •  1.8 
Homogenates were prepared from kidneys of normal and 
beige mice induced  for 23 days with dihydrotestosterone. 
Values  are mean •  SEM for three experiments. 
normal  mouse  urine  and  of mixtures  of the  two 
have  not  revealed  the  presence  of  inhibitors  or 
activators.  Furthermore,  by single radial immuno- 
diffusion  analyses,  equal  glucuronidase  activity 
units from beige and normal mouse urine produced 
equal  ring  diameters  after  specific enzyme  stain- 
ing, indicating that  the lower glucuronidase  activ- 
ity in  beige mouse  urine  is due  to the presence of 
fewer glucuronidase  molecules than  are  found  in 
normal  mouse urine. 
The  urinary  protein  analyses  (Table  VI)  show 
that  in  both  types  of  mice  androgen  treatment 
causes  a  four-  to  fivefold increase  in  proteinuria. 
Much  of  this  urinary  protein  is  known  to  be  a 
serum-protein  complex of average mol wt  17,800, 
whose synthesis is induced in liver by androgen (6, 
7).  Unlike the lysosomal enzymes, there appears to 
be little difference between normal and beige mice, 
whether control or induced, in total urinary protein 
content.  Beige mice,  therefore,  are  not  altered  in 
the general processes  of glomerular filtration and 
excretion of proteins. 
CONCLUSIONS 
The principal conclusion of our studies  is that the 
beige mutant  is defective in the normal process of 
extruding  lysosomal enzymes through  the plasma 
membrane  of the kidney tubule cells. As a  result, 
there  is  a  significant  accumulation  of lysosomal 
enzymes  in  the  kidney,  especially  after  enzyme 
synthesis  has  been  stimulated  by  androgen.  AI- 
TAaLE VI 
Daily Secretion of L  ysosomal Enzymes and Protein by Normal and Beige Mice 
No androgen  Androgen 
C57BL/6J  C57BL/6J  C57BL/6J  C57BL/6J 
(+ / +)  (bg/bg)  (+ / +)  (bg/bg) 
Glucuronidase 
Secreted (U)  0.068 ~: 0.007  0.029 •  0.003  17.8 + 0.70  4.98 4- 0.43 
Secreted* (%)  4.2  1.2  41  3.3 
Galactosidase 
Secreted (U)  0.327 :~ 0.037  0.079 4- 0.003  9.18 •  0.80  2.34 •  0.18 
Secreted* (%)  5.6  1.0  97  13 
Hexosaminidase 
Secreted (U)  2.78 :~ 0.38  2.00 •  0.15  15.2 •  0.80  5.08 •  0.61 
Secreted* (%)  4.5  2.3  12  2.4 
Protein 
Excreted (mg)  5.26 ~ 0.58  3.88 •  0.12  23.5 4- 2.4  22.0 +  1.5 
* Percent of total kidney activity. Values  are mean •  SEM for 24-h  urine samples  collected on 4 consecutive days 
starting on day 23 of treatment for androgen-treated mice. Uninduced control levels are significantly different for 
glucuronidase (P <  0.01) and galactosidase (P  <  0.01)  but are not different for hexosaminidase or protein. Induced 
values for all three enzymes but not protein are different (P  <  0.001) for normal and beige mice. 
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kidney  of  beige  mice  could  be  caused  by  an 
increased  rate  of synthesis,  recent  studies  have 
demonstrated that the rate of synthesis of kidney 
glucuronidase is identical in beige and normal mice 
(Brandt  and  Swank,  manuscript  in  preparation). 
For glucuronidase, the increase in activity has been 
shown by immunologic and electrophoretic analy- 
ses to result from accumulation of the same species 
of  molecules that  are  present  in  the  kidneys  of 
normal  mice.  This  effect  is tissue  specific as  no 
significant increase of lysosomal enzyme activity 
occurred in any of five other organs of beige mice. 
Since these organs are not known to synthesize and 
release  large  amounts  of lysosomal enzymes,  it 
appears that  the  beige mutation  causes a  signifi- 
cant elevation of lysosomal enzymes only in tissues 
where secretion or excretion is a major mechanism 
of  lysosomal  enzyme  turnover.  In  kidneys  of 
androgen-stimulated beige mice the secretion of all 
three  lysosomal enzymes  is  lowered  by approxi- 
mately the same factor when compared to normal 
mice. The simplest, though not the only, interpre- 
tation of this observation is that all three enzymes 
are  enclosed  in  the  same  lysosome,  which  then 
under  normal  conditions  undergoes  exocytosis 
through the plasma membrane. 
A  second conclusion is that the beige mutation 
does not affect the physiology of other subcellular 
organelles.  Kidneys  of  beige  mice  had  normal 
levels of marker enzymes for the cytosol, peroxi- 
somes,  and  mitochondria.  Also, other  androgen- 
induced enzymes, D-amino acid oxidase and alco- 
hol  dehydrogenase,  that  are not  present  in  lyso- 
somes are at equal levels in  kidneys from  andro- 
gen-treated normal and beige mice. 
There  is  no  gross  alteration  in  total  lipid, 
carbohydrate,  or  protein  content  in  androgen- 
treated beige mouse kidney. This suggests that the 
20-30%  increase in  kidney weight  in  beige mice 
after  androgen  administration  is  due  to  parallel 
accumulation  of all three kinds of major cellular 
constituents, although our analyses suggest that a 
significant  fraction  of  the  accumulated  protein 
may be lysosomal enzymes. These data do not, of 
course, exclude a  more  specific abnormality in  a 
lipid or carbohydrate such as is known to occur in 
several lysosomal lipid storage diseases (20). 
The  specific action  of the  beige gene  on  lyso- 
some physiology is further emphasized by the fact 
that the increase in glucuronidase activity appears 
to be confined to the lysosomal component of this 
enzyme,  since  the  beige  mutant  does  not  have 
elevated glucuronidase microsomal component. 
The subcellular fractionation showed a doubling 
in  microsomal  glucuronidase  activity  in  beige 
mice, but by electrophoretic analysis practically all 
this doubling was due to increase in the L compo- 
nent  which  is found  in  lysosomes. This  fact  sug- 
gests that the higher microsomal glucuronidase in 
beige kidney is a  contaminant  from  broken lyso- 
somes  rather  than  a  microsomal  form  of  the 
enzyme which is affected by the beige mutation. 
After osmotic shock treatment  a large fraction 
of glucuronidase is found in the  soluble fraction. 
However, by electrophoretic analysis, soluble glu- 
curonidase has the  same  molecular properties as 
normal  lysosomal  enzyme,  supporting  the  view 
that soluble glucuronidase in kidneys of beige mice 
arises from  rupture of the giant lysosomes during 
homogenization. That glucuronidase in the soluble 
fraction arises from broken lysosomes is supported 
by the fact that a large fraction of ~3-galactosidase, 
another marker enzyme for lysosomes, is found in 
the  soluble  fraction  after  homogenization  under 
the same conditions used in these experiments (A. 
Lusis,  G.  Breen,  and  K.  Paigen,  manuscript  in 
preparation).  Also,  in  mink  with  the  Chediak- 
Higashi syndrome, an unusually large amount of 
acid phosphatase is solubilized during homogeni- 
zation  (41),  further  emphasizing  the  fragility of 
lysosomes in animals with this disease. 
Together  with  the  biochemical measurements, 
the  histological  studies  show  that  in  the  beige 
mutant there is a  massive accumulation of glucu- 
ronidase-containing giant  lysosomes after andro- 
gen treatment. The majority of the cellular glucu- 
ronidase  appears concentrated  in  these  granules. 
It also is notable that there is an abrupt change in 
size of these lysosomes in beige kidney across the 
cortex, with the lysosomes near the corticomedul- 
lary boundary ($3  region) reaching  10  11  ~m  in 
diameter. This region contains the distal portion of 
the proximal convoluted tubule. Essner and Oliver 
(4) have recently reported that this same region of 
kidney  of  beige  mice  contains  numerous  large 
polysaccharide-rich granules not present in normal 
mice. One possible reason the lysosomes in kidney 
of beige mice are particularly large here might be 
that cells at the distal portion of the tubule actively 
phagocytose  lysosomal  enzymes  released  from 
cells nearer the glomerulus. Alternatively. cells in 
the $3 region may have different rates of turnover 
of lysosomal enzymes. 
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of lysosomal enzymes in addition to glucuronidase 
may be increased in mouse kidney after stimula- 
tion by androgens. It  is now established that the 
rate of glucuronidase synthesis is elevated 20- to 
50-fold by androgen treatment (36).  Because kid- 
ney levels  of other lysosomal enzymes show little 
or  no  increase after  androgen administration, it 
has  been  assumed that  these  lysosomal enzymes 
were  not induced. However, the data in Table VI 
show that the loss by secretion of galactosidase in- 
creases about 30-fold and that of hexosaminidase 
about  5-fold  after  implantation  of  testosterone 
pellets. The most likely mechanism for balancing 
these greatly increased secretion rates and main- 
taining constant tissue enzyme levels is  a  corre- 
sponding increase in the rate of enzyme synthesis. 
The probability that  androgens induce a  general 
increase  in  biosynthesis of  many  iysosomal en- 
zymes makes mouse kidney an attractive system 
for studying the molecular aspects of the biosyn- 
thesis of this very important organelle. 
The molecular abnormality resulting in lowered 
lysosomal  enzyme  extrusion  from  beige  kidney 
cells  remains  unknown.  At  least  two  general 
alterations are possible: a lowered mobility of the 
giant  lysosomes within the  cell,  or an  abnormal 
fusion of iysosomes with  the  plasma  membrane 
during  exocytosis.  Recent  studies  have  demon- 
strated  that  capping  of  concanavalin A  plasma 
membrane receptors occurs more readily in beige 
polymorphonuclear  leukocytes  than  in  normal 
leukocytes  (22).  This  phenomenon  is  consistent 
with  the  lysosomal secretion defect  we  have  ob- 
served in that it could be due either to an alteration 
of  the  plasma  membrane  in  beige  mice  or  to 
alterations in the microtubular system which  pre- 
sumably controls the intracellular mobility of both 
the  concanavalin A  receptors  and  lysosomes (3, 
39).  Two  studies  have  shown  that  intravenously 
injected horseradish  peroxidase  is  pinocytosed at 
normal  rates  in  kidney  of  beige  mice  but  is 
subsequently hydrolyzed at a much slower rate (5, 
30). The slow rate of hydrolysis in beige mice may 
not be a  result of defective protein hydrolysis per 
se. Rather, there may be a problem of delivery, i.e. 
either  migration  of  phagosomes  and  lysosomes 
within  the  cell,  or  fusion  of  the  two  types  of 
granules may be defective in the same manner in 
which we observe a defect in delivery of lysosomal 
enzymes  through  the  plasma  membrane  to  the 
kidney tubule lumen. 
A  decreased  rate  of delivery of the content of 
phagocytic  vesicles  to  lysosomes  has  been  de- 
scribed  in  leukocytes  of  patients  with  Chediak- 
Higashi syndrome (23, 42).  It is possible that the 
increased susceptibility to  infection seen  in Che- 
diak-Higashi  patients  and  in  beige  mice  results 
from such a defect. This abnormality may have the 
same molecular basis as the lowered secretion of 
lysosomal enzymes from the kidneys of beige mice. 
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